Get the Stockscreener App
3.726
0.93%
-0.034
Cargo Therapeutics Inc stock is traded at $3.726, with a volume of 233.28K.
It is down -0.93% in the last 24 hours and up +2.05% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$3.76
Open:
$3.78
24h Volume:
233.28K
Relative Volume:
0.29
Market Cap:
$173.52M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.0391
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-4.49%
1M Performance:
+2.05%
6M Performance:
-79.01%
1Y Performance:
-85.14%
1-Day Range:
$3.71
$3.84
1-Week Range:
$3.59
$3.96
52-Week Range:
$3.00
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.725 | 173.52M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.63 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
688.49 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
634.75 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.35 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
112.69 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction (NASDAQ:CRGX) - Seeking Alpha
CARGO Therapeutics Discloses Strategic Corporate Presentation via SEC Filing - Defense World
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Layoff Tracker: Lava, Ryvu Cutting 30% of Their Workforces - BioSpace
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, IncCRGX - PR Newswire
IPOs Numbers Rise In 2024, But Dwindling Returns Could Diminish Potential In 2025 - Citeline News & Insights
CARGO Therapeutics Highlights Progress in CAR T Therapy - TipRanks
Levi & Korsinsky Reminds CARGO Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsCRGX - ACCESS Newswire
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus Price Target from Analysts - MarketBeat
After Plunging -69.58% in 4 Weeks, Here's Why the Trend Might Reverse for CARGO Therapeutics, Inc. (CRGX) - Yahoo Finance
You might want to take a look at CARGO Therapeutics Inc (CRGX) now - SETE News
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
CARGO Therapeutics, Inc. (CRGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
ATTENTION CARGO Therapeutics, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Shareholders to Inquire about Securities Investigation - Markets Insider
Here's Why CARGO Therapeutics, Inc. (CRGX) Could be Great Choice for a Bottom Fisher - Yahoo Finance
41,124 Shares in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Bought by abrdn plc - Defense World
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - News & Insights
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Connect - Markets Insider
Full List of Companies in California Laying Off Employees This Year - Newsweek
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Reach Out - Markets Insider
Quarterly Snapshot: Quick and Current Ratios for CARGO Therapeutics Inc (CRGX) - The Dwinnex
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Stockholders to Inquire about Securities Investigation - Markets Insider
Stock Market Movers: FOXX and AMOD Surge While CRGX and CRKN Face Sharp Declines - HPBL
Evaluating the Ups and Downs of CARGO Therapeutics Inc’s (CRGX) Stock - The News Heater
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Investors to Learn More About the Investigation - Markets Insider
Research Analysts Set Expectations for CRGX Q1 Earnings - MarketBeat
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. - GuruFocus.com
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - Longview News-Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Connect - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Did CARGO Therapeutics Inc (CRGX) perform well in the last session? - US Post News
Closing Bell Recap: CARGO Therapeutics Inc (CRGX) Ends at 3.65, Reflecting a 1.39 Upturn - The Dwinnex
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Truist Financial - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Cut to Neutral at Chardan Capital - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Neutral at HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by William Blair - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Hold at Jefferies Financial Group - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Neutral" Rating by Piper Sandler - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Lowered to "Underweight" Rating by JPMorgan Chase & Co. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - Markets Insider
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
Cargo Therapeutics stock tumbles after trial setback - MSN
HC Wainwright Expects Higher Earnings for CARGO Therapeutics - Defense World
William Blair Has Optimistic Outlook of CRGX Q1 Earnings - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Reach Out - Markets Insider
CARGO Therapeutics (NASDAQ:CRGX) Sets New 1-Year Low – Here’s What Happened - Defense World
Stock summary: CARGO Therapeutics reflected weekly fall of 73.11% - Business Upturn
Piper Sandler Downgrades CARGO Therapeutics (NASDAQ:CRGX) to Neutral - Defense World
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):